Received Feb 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| PNC15 | PNEUMO (VAXNEUVANCE) | MERCK & CO. INC. | UNK | Z006429 | — |
the patient did not have any symptoms or allergic reactions; only a partial dose of VAXNEUVANCE was given to a 15-month-old patient due to a situation with the patient that would not allow the full dose to be administered.; This spontaneous report was received from an other health professional and referred to a 15-month-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 03-Feb-2026, the patient vaccinated with Pneumococcal 15-valent Conjugate Vaccine (VAXNEUVANCE) (lot #Z006429, expiration date was not reported but upon internal validation established as 02-Oct-2027, a partial dose, once, strength and route unknown) for prophylaxis due to a situation with the patient that would not allow the full dose to be administered (Intentional underdose). The patient did not have any symptoms or allergic reactions (No adverse event) and a full dose of the medication was planned to be administered at a later date.